Sl. Kelly et al., MODE OF ACTION AND RESISTANCE TO AZOLE ANTIFUNGALS ASSOCIATED WITH THE FORMATION OF HA-METHYLERGOSTA-8,24(28)-DIEN-3-BETA,6-ALPHA-DIOL, Biochemical and biophysical research communications, 207(3), 1995, pp. 910-915
Azole antifungal compounds inhibit sterol 14 alpha-demethylase. They a
re used extensively for the treatment of immunocompromised patients wh
ere fungal infection is common and often results in death. Resistance
to the compounds is emerging, particularly in fungal pathogens obtaine
d from AIDS patients undergoing prolonged therapy. We show here that c
ell growth arrest correlates with the accumulation of 14 alpha-methyl-
ergosta-8,24(28)-dien-3 beta,6 alpha-diol in a yeast strain with a ste
rol 14 alpha-demethylase gene disruption, which mimics stringent treat
ment conditions. Cells can overcome the effect of such a block by a su
ppressor mutation in sterol Delta(5,6) desaturation and acquire azole
resistance. Plasmid-based complementation of the sterol 14 alpha-demet
hylase defect does not alter the azole susceptibility of strains conta
ining these suppressor mutations, showing resistance is due entirely t
o the Delta(5,6) desaturase defect. (C) 1995 Academic Press, Inc.